GAD2 and type 1 diabetes mellitus: The binding specificities of serum autoantibodies from uncomplicated and complicated (Nephropathic and retinopathic) T1D patients were evaluated by competitive ELISA using N-GAD65 and ROS-GAD65 as inhibitors.